LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

722

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 90100 aerosol foam

LEO 90100 aerosol foam twice weekly

DRUG

LEO 90100 aerosol foam vehicle

LEO 90100 aerosol foam vehicle twice weekly

Trial Locations (58)

10029

Mount Sinai School of Medicine, New York

10075

Sadick Research Group, New York

14623

Skin Search of Rochester, Rochester

15213

UPMC Department of Dermatology, Pittsburgh

15831

Michael Sebastian, Mahlow

20354

SCIderm GmbH, Hamburg

20850

DermAssociates, Rockville

23538

UKSH - Campus Lübeck, Lübeck

26000

Centre Hospitalier de Valence, Valence

29609

CHRU de Brest - Hôpital Morvan, Brest

33144

International Dermatology Research, Miami

35033

CHU de Rennes - Hôpital Pontchaillou, Rennes

37072

Rivergate Dermatology Clinical Research Center, Goodlettsville

37215

Tennessee Clinical Research Center, Nashville

37922

The Skin Wellness Center, Knoxville

40217

Derm Research, Louisville

42055

C.H.U. de Saint-Etienne Service de Dermatologie, Saint-Etienne

48202

Henry Ford Medical Center - New Center One, Detroit

48346

Clarkston Skin Research, Clarkston

49009

Beyer Research, Kalamazoo

54122

Universitätsklinikum Essen (AöR), Klinik für Dermatologie, Essen

60005

Arlington Dermatology, Arlington Heights

77598

Center for Clinical Studies, Webster

78229

Clinical Trials of Texas, San Antonio

80210

Colorado Medical Research Center, Denver

80337

LMU Poliklinik Derma & Allergo, München

90404

Clinical Science Institute, Santa Monica

91054

Universitätsklinikum Erlangen, Erlangen

94538

Center for Dermatology Clinical Research, Fremont

97421

Gemein. Weber & Crainic, Schweinfurt

99202

Premier Clinical Research, Spokane

08520

Psoriasis Treatment Center of Central NJ, East Windsor

V3R 6A7

Dr. Chih-ho Hong Medical, Surrey

V6E 4M3

Pacific Dermaesthetics, Vancouver

R3M 3Z4

Wiseman Dermatology Research, Winnipeg

E2A 4Z9

Maritime Medical Research Centre, Bathurst

E3B 1G9

Brunwick Dermatology Center, Fredericton

L1S 7K8

CCA Medical Research, Ajax

L8N 1V6

Dermatrials Research Incorporated, Hamilton

N6A 3B4

The Guenther Dermatology Research Centre, London

L3P 1X2

Lynderm Research, Markham

K9J 5K2

SKiN Center for Dermatology, Peterborough

N2J 1C4

K. Papp Clinical Research, Waterloo

J2B 5L4

Clinique du Dre Isabelle Delorme Inc, Québec

06202

C.H.U. de nice, Hôpital de l'Archet II, Service de Dermatologie-Vénérologie, Nice

01307

Klinik und Poliklinik für Dermatologie, Dresden

07548

SRH Wald-Klinikum Gera, Gera

31-123

Małopolskie Centrum Kliniczne, Krakow

20-079

NZOZ Med-laser, Lublin

60-425

Solumed, Poznan

35-030

Kliniczny Szpital Wojewódzki, Klinika Dermatologii, Rzeszów

PE8 6PL

Wansford and Kings Cliffe Prac, Wansford

S40 4AA

Ashgate Medical Practice, Chesterfield

LE10 2SE

Burbage Surgery, Burbage

NN8 4RW

Albany House Medical Centre, Wellingborough

CV32 4RA

Sherbourne Medical Centre, Royal Leamington Spa

LS7 4SA

Chapel Allerton Hospital, Leeds

M6 8HD

Dermatopharmacology Department, Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY